FTC Substantiation Standard for Health Claims

An FDA label or product position does not close an FTC ad review. The two tracks ask different questions. For an ad, first write down each claim stated in plain words. Then list each fact a reader may infer from the whole page. Before any claim goes live, match it to proof that fits the exact product, group, result, and time span. The Federal Trade Commission says ads must be true, not misleading, and backed before they run. It also reviews the full net impression. This guide is a review aid for United States ads. It is not legal advice or a finding about a live page.

Begin with the ad that a reader can see

Save the full ad before review. For a web page, keep the title, text, images, charts, buttons, footnotes, reviews, and links. Also save the page date and version. A short phrase can take on a wider meaning when it sits next to an image or a sales prompt.

Do not start with the study file. Start with the message. The same paper may fit one narrow claim but not a wider one. The reviewer must know which claim the ad makes before judging the proof.

The FTC Health Products Compliance Guidance says its ad rules apply to both direct and implied claims. It also looks at the net impression made by all key parts of the ad. The guidance is FTC staff guidance. It says it is not a rule or a safe path for all facts. This article does not present it as a court ruling.

Separate express claims from implied claims

An express claim is stated in words or other clear content. A line that says a product will cause a set result is express. A purity figure, test claim, or claim about a study can also be express when it states a fact that can be checked.

An implied claim is a fact a reader may take from the ad even when the words do not state it. A product name, image, chart, review, or link may add that message. A set of weak cues can work as one strong claim when a reader sees them at once.

Write each claim as a short sentence. Keep more than one reading when both are fair. Do not reject a reading only because the writer says it was not meant. Net impression review asks what the ad may convey, not just what the team hoped to say.

For each claim, mark whether it is about identity, test results, quality, health benefit, safety, time to result, size of result, or another fact. This label helps the team ask for the right kind of proof.

Read the net impression as one unit

The FTC guidance says words, names, images, charts, and other parts can work together. Review the page in the order a reader may see it. Start with the first screen. Then read the rest of the page, linked proof, reviews, and the sales action.

Check what is close to the product. An article about a body result may add meaning when it is placed next to a product and a buy button. A chart may imply a change even when its title is mild. A review may convey an outcome that the main copy does not state.

Also check what is left out. A missing limit may make a narrow fact look broad. If a result came from a cell test, keep that model in the claim. If a report covers one sample, do not let the page imply that it proves a health result.

A footnote does not erase the rest of the page. Read the claim and the note together. If they point in two different ways, revise the main claim.

Require proof before publication

The FTC guidance says support must exist before an ad runs. A later study does not show what the advertiser had at the time of publication. The review file should thus record the proof, the date held, and the claim version before release.

Use a claim record with these fields:

1. the exact claim and a saved copy of the ad;

2. each fair express or implied reading;

3. the product and facts named by the claim;

4. the proof held before the planned release;

5. the source, date, study type, and key limits;

6. the fit between the proof and the claim;

7. the review result and person who made it; and

8. the event that will cause a new review.

Do not use the file as a stamp that makes a claim lawful. It is a record of the work done. Counsel must decide legal questions tied to a real ad and its facts.

Match the proof to the exact claim

Proof about one item does not always fit another item. Record the tested material and form. Note the group or model. Keep the route, result, time span, and test setting with the finding. State what the source did not test.

For a health benefit claim, the FTC guidance says animal and lab work alone is not enough to support a claim about people. It says well run human trials are the usual type of proof for such claims. The exact proof still depends on the claim and the field. Do not turn that statement into one fixed study count for every ad.

Ask these fit questions:

1. Was the same product or a sound match tested?

2. Did the source study the group named or implied by the ad?

3. Did it measure the result the ad states?

4. Did the time span fit the claim?

5. Did the method allow the source to answer that question?

6. Did the review include limits and facts that point another way?

If a key point is not known, write not established. Do not fill the gap with a broad claim.

Use a claim map for the full page

A simple map can keep the review tied to the ad.

Do not average the rows into one score. One clear unsupported claim still needs repair even when the rest of the page is careful.

For a review of claims made through partners, see Peptide Affiliate and Testimonial Compliance.

Treat disclosures as part of the claim

A disclosure can add a needed limit when a reader can notice and grasp it. It should sit close to the claim in the form in which the ad appears. A link or note that is hard to find may not change the main message.

More to the point, a disclosure should not fight the claim it seeks to narrow. If a bold line makes a human result claim, a small note about lab research does not make both messages fit. Change or remove the main claim.

The same rule applies to reviews and expert quotes. A review can make an objective claim. Naming the speaker does not remove the need for proof that fits the ad message. The claim map should include the review and the way the page frames it.

Keep FDA intended use review on its own track

21 CFR 201.128 defines intended use through objective intent in its stated federal drug setting. It lists labels, ads, and written or oral claims as facts that may show intent. That is an FDA related rule. It does not replace the FTC test for ad proof.

The Prime Sciences warning letter dated March 31, 2026 gives one current agency example. FDA said research only text did not undo other site text that showed human drug intent. The letter states FDA findings about that site. It is an agency notice, not a court ruling and not a final result for all sellers.

Use those FDA sources to review intended use issues within their scope. Do not use an FDA label, letter, database entry, or product position as FTC clearance. In the other direction, an FTC claim review does not decide FDA status. Ask counsel to review both tracks when both may apply.

Record the release choice in plain words

After the review, record one of four work choices: keep the claim, narrow it, remove it, or send it to counsel. These are workflow notes, not legal outcomes.

For a kept claim, state the proof and why it fits. For a narrow claim, save the old and new text. For a removed claim, note the gap. For counsel review, give the full ad, claim map, sources, and open questions.

The reviewer should also check that the approved text appears in every place. A title, image text, email, social post, or old page may still hold the prior claim. Keep the release tied to a page version and date.

Reopen the review when facts change

Set clear triggers for a new review. A new study, product form, customer group, image, review, sales channel, or agency source can change the claim map. A small copy change can also change the net impression.

Save the new ad and repeat the claim and proof match. Prior approval does not cover a new message by default. Monitoring does not guarantee compliance. It keeps the record tied to what readers can see now.

Frequently Asked Questions

Does an FDA position clear an ad for FTC review?

No. FDA and FTC tracks ask different questions. An FDA label or product position does not show that every express or implied ad claim has proof that fits. The FTC review still starts with the ad and the evidence held before it ran.

What is an express claim?

It is a claim stated in words, images, or other direct content. A claim about a test result, product trait, health result, or time to result can be express when the ad states it in a way that can be checked.

What is an implied claim?

It is a message a reader may take from the full ad even when no one line says it. Names, images, charts, reviews, links, and context can create the message together. Write down each fair reading before checking proof.

Can a disclaimer fix an unsupported claim?

Not when it fights the main message. A clear note may narrow a claim when it is close and easy to grasp. It should not be used to excuse a bold claim that points the other way. Revise or remove the claim.

Is FTC guidance a court ruling?

No. The cited health products document is FTC staff guidance and says it is nonbinding. It helps show the agency view and a review method. It does not decide a live case or promise a legal result.

Sources

1. Federal Trade Commission, Health Products Compliance Guidance.

2. Electronic Code of Federal Regulations, 21 CFR 201.128, Intended Uses.

3. Food and Drug Administration, Prime Sciences Warning Letter dated March 31, 2026.

Educational and legal disclaimer

This page is for education and ad review. It is not legal, medical, or lab advice. It gives no human use or dose guide. It does not decide the status of a product, page, or claim. It does not promise safety, sales, trust, compliance, or any legal result. Qualified counsel should review a real ad and the rules that apply to it.